These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 17671882)
1. Role of bromelain in the treatment of patients with pityriasis lichenoides chronica. Massimiliano R; Pietro R; Paolo S; Sara P; Michele F J Dermatolog Treat; 2007; 18(4):219-22. PubMed ID: 17671882 [TBL] [Abstract][Full Text] [Related]
9. Pityriasis lichenoides chronica: good response to photodynamic therapy. Fernández-Guarino M; Harto A; Reguero-Callejas ME; Urrutia S; Jaén P Br J Dermatol; 2008 Jan; 158(1):198-200. PubMed ID: 18028490 [No Abstract] [Full Text] [Related]
10. The relation between toxoplasmosis and pityriasis lichenoides chronica. Nassef NE; Hammam MA J Egypt Soc Parasitol; 1997 Apr; 27(1):93-9. PubMed ID: 9097531 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the therapeutic effects of narrow band UVB vs. PUVA in patients with pityriasis lichenoides. Farnaghi F; Seirafi H; Ehsani AH; Agdari ME; Noormohammadpour P J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):913-6. PubMed ID: 21054568 [TBL] [Abstract][Full Text] [Related]
12. The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girl. Niemczyk UM; Zollner TM; Wolter M; Staib G; Kaufmann R Br J Dermatol; 1997 Dec; 137(6):983-7. PubMed ID: 9470920 [TBL] [Abstract][Full Text] [Related]
13. Role of streptococcal infection in the etiopathogenesis of pityriasis lichenoides chronica and the therapeutic efficacy of azithromycin: a randomized controlled trial. Elbendary A; Youssef R; Abdel-Halim MRE; Abdel Halim D; El Sharkawy DA; Alfishawy M; Gad MA; Gad A; Elmasry MF Arch Dermatol Res; 2023 Apr; 315(3):521-530. PubMed ID: 36129521 [TBL] [Abstract][Full Text] [Related]
14. Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. Pinton PC; Capezzera R; Zane C; De Panfilis G J Am Acad Dermatol; 2002 Sep; 47(3):410-4. PubMed ID: 12196751 [TBL] [Abstract][Full Text] [Related]
15. [Pityriasis lichenoides chronica--a new indication for PUVA therapy? (author's transl)]. Hofmann C; Weissmann I; Plewig G Dermatologica; 1979; 159(6):451-60. PubMed ID: 510649 [TBL] [Abstract][Full Text] [Related]
17. Differentiation and clonality of lesional lymphocytes in pityriasis lichenoides chronica. Shieh S; Mikkola DL; Wood GS Arch Dermatol; 2001 Mar; 137(3):305-8. PubMed ID: 11255329 [TBL] [Abstract][Full Text] [Related]
18. Pityriasis lichenoides chronica presenting with bilateral palmoplantar involvement. Avshalumova L; Richardson B; Miller R Cutis; 2016 May; 97(5):345;347;358. PubMed ID: 27274548 [TBL] [Abstract][Full Text] [Related]
19. A case report of pityriasis lichenoides in a patient with chronic hepatitis C. Zechini B; Teggi A; Antonelli M; Persechino S; Pranteda G; Versace I; Pasquazzi C; Aceti A J Infect; 2005 Aug; 51(2):E23-5. PubMed ID: 16038744 [TBL] [Abstract][Full Text] [Related]
20. Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate. López-Ferrer A; Puig L; Moreno G; Camps-Fresneda A; Palou J; Alomar A Eur J Dermatol; 2010; 20(4):511-2. PubMed ID: 20395191 [No Abstract] [Full Text] [Related] [Next] [New Search]